These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 31354265)

  • 1. Cholesterol-rich lipid-mediated nanoparticles boost of transfection efficiency, utilized for gene editing by CRISPR-Cas9.
    Hosseini ES; Nikkhah M; Hosseinkhani S
    Int J Nanomedicine; 2019; 14():4353-4366. PubMed ID: 31354265
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid composition of cationic nanoliposomes implicate on transfection efficiency.
    Ghanbari Safari M; Hosseinkhani S
    J Liposome Res; 2013 Sep; 23(3):174-86. PubMed ID: 23594237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization, and efficient transfection of cationic liposomes and nanomagnetic cationic liposomes.
    Samadikhah HR; Majidi A; Nikkhah M; Hosseinkhani S
    Int J Nanomedicine; 2011; 6():2275-83. PubMed ID: 22072865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How does the spacer length of cationic gemini lipids influence the lipoplex formation with plasmid DNA? Physicochemical and biochemical characterizations and their relevance in gene therapy.
    Muñoz-Úbeda M; Misra SK; Barrán-Berdón AL; Datta S; Aicart-Ramos C; Castro-Hartmann P; Kondaiah P; Junquera E; Bhattacharya S; Aicart E
    Biomacromolecules; 2012 Dec; 13(12):3926-37. PubMed ID: 23130552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical properties of cationic nanoemulsions and liposomes obtained by microfluidization complexed with a single plasmid or along with an oligonucleotide: Implications for CRISPR/Cas technology.
    Schuh RS; Poletto É; Fachel FNS; Matte U; Baldo G; Teixeira HF
    J Colloid Interface Sci; 2018 Nov; 530():243-255. PubMed ID: 29982016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery.
    Zhang Y; Li H; Sun J; Gao J; Liu W; Li B; Guo Y; Chen J
    Int J Pharm; 2010 May; 390(2):198-207. PubMed ID: 20116418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral vector mimicking and nucleus targeted nanoparticles based on dexamethasone polyethylenimine nanoliposomes: Preparation and evaluation of transfection efficiency.
    Malaekeh-Nikouei B; Gholami L; Asghari F; Askarian S; Barzegar S; Rezaee M; Kazemi Oskuee R
    Colloids Surf B Biointerfaces; 2018 May; 165():252-261. PubMed ID: 29494955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol-dependent macropinocytosis and endosomal escape control the transfection efficiency of lipoplexes in CHO living cells.
    Cardarelli F; Pozzi D; Bifone A; Marchini C; Caracciolo G
    Mol Pharm; 2012 Feb; 9(2):334-40. PubMed ID: 22196199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery.
    He ZY; Zheng X; Wu XH; Song XR; He G; Wu WF; Yu S; Mao SJ; Wei YQ
    Int J Pharm; 2010 Sep; 397(1-2):147-54. PubMed ID: 20667672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoplexes versus nanoparticles: pDNA/siRNA delivery.
    Khurana B; Goyal AK; Budhiraja A; Aora D; Vyas SP
    Drug Deliv; 2013 Feb; 20(2):57-64. PubMed ID: 23537464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-responsive destabilization of stabilized plasmid-lipid nanoparticles as an efficient gene delivery.
    Song SJ; Lee S; Lee Y; Choi JS
    Eur J Pharm Sci; 2016 Aug; 91():20-30. PubMed ID: 27240779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting DNA binding and stability of association to cationic liposomes.
    Even-Chen S; Cohen R; Barenholz Y
    Chem Phys Lipids; 2012 May; 165(4):414-23. PubMed ID: 22715503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stearyl polyethylenimine complexed with plasmids as the core of human serum albumin nanoparticles noncovalently bound to CRISPR/Cas9 plasmids or siRNA for disrupting or silencing PD-L1 expression for immunotherapy.
    Cheng WJ; Chen LC; Ho HO; Lin HL; Sheu MT
    Int J Nanomedicine; 2018; 13():7079-7094. PubMed ID: 30464460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic Polymer-Mediated CRISPR/Cas9 Plasmid Delivery for Genome Editing.
    Zhang Z; Wan T; Chen Y; Chen Y; Sun H; Cao T; Songyang Z; Tang G; Wu C; Ping Y; Xu FJ; Huang J
    Macromol Rapid Commun; 2019 Mar; 40(5):e1800068. PubMed ID: 29708298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoplexes from Non-viral Cationic Vectors: DOTAP-DOPE Liposomes and Gemini Micelles.
    Falsini S; Ristori S
    Methods Mol Biol; 2016; 1445():33-43. PubMed ID: 27436311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene editing of MPS I human fibroblasts by co-delivery of a CRISPR/Cas9 plasmid and a donor oligonucleotide using nanoemulsions as nonviral carriers.
    Schuh RS; de Carvalho TG; Giugliani R; Matte U; Baldo G; Teixeira HF
    Eur J Pharm Biopharm; 2018 Jan; 122():158-166. PubMed ID: 29122734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What the cell surface does not see: The gene vector under the protein corona.
    Motta S; Rondelli V; Cantu L; Del Favero E; Aureli M; Pozzi D; Caracciolo G; Brocca P
    Colloids Surf B Biointerfaces; 2016 May; 141():170-178. PubMed ID: 26852100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physico-chemical characterisation and transfection efficiency of lipid-based gene delivery complexes.
    Birchall JC; Kellaway IW; Mills SN
    Int J Pharm; 1999 Jun; 183(2):195-207. PubMed ID: 10361170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophysical and lipofection studies of DOTAP analogs.
    Regelin AE; Fankhaenel S; Gürtesch L; Prinz C; von Kiedrowski G; Massing U
    Biochim Biophys Acta; 2000 Mar; 1464(1):151-64. PubMed ID: 10704929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase behavior, DNA ordering, and size instability of cationic lipoplexes. Relevance to optimal transfection activity.
    Simberg D; Danino D; Talmon Y; Minsky A; Ferrari ME; Wheeler CJ; Barenholz Y
    J Biol Chem; 2001 Dec; 276(50):47453-9. PubMed ID: 11564736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.